|
|
Volumn 4, Issue 2, 2008, Pages 337-352
|
|
Update on the use of pramipexole in the treatment of Parkinson's disease
|
|
Author keywords
Adverse events; Efficacy; Parkinson's disease; Pramipexole
|
|
Indexed keywords
1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE;
BROMOCRIPTINE;
CABERGOLINE;
CATECHOL METHYLTRANSFERASE INHIBITOR;
CLONAZEPAM;
DOPAMINE RECEPTOR STIMULATING AGENT;
ENTACAPONE;
LEVODOPA;
MODAFINIL;
MONOAMINE OXIDASE B INHIBITOR;
PERGOLIDE;
PLACEBO;
PRAMIPEXOLE;
ROPINIROLE;
ROTIGOTINE;
SERTRALINE;
TOLCAPONE;
ADD ON THERAPY;
ADJUVANT THERAPY;
ANHEDONIA;
APATHY;
APPLICATION SITE REACTION;
CELLULITIS;
CLINICAL EFFECTIVENESS;
CLINICAL TRIAL;
COGNITIVE DEFECT;
COMBINATION CHEMOTHERAPY;
CONFUSION;
CONSTIPATION;
COST EFFECTIVENESS ANALYSIS;
DELUSION;
DEPRESSION;
DISABILITY;
DISEASE SEVERITY;
DIZZINESS;
DOSE RESPONSE;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG CLEARANCE;
DRUG DOSE TITRATION;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG MEGADOSE;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG TREATMENT FAILURE;
DRUG WITHDRAWAL;
DYSKINESIA;
DYSPHAGIA;
DYSTONIA;
EDEMA;
FATIGUE;
FEEDING BEHAVIOR;
FIBROMYALGIA;
GASTROINTESTINAL SYMPTOM;
HALLUCINATION;
HEART VALVE REGURGITATION;
HUMAN;
HYPERSEXUALITY;
HYPOTENSION;
IMPULSE CONTROL DISORDER;
LEG EDEMA;
LOW DRUG DOSE;
MONOTHERAPY;
MOTOR DYSFUNCTION;
NAUSEA;
NEUROPROTECTION;
NEUROTOXICITY;
NONHUMAN;
ORTHOSTATIC HYPOTENSION;
PARASOMNIA;
PARKINSON DISEASE;
PARKINSONISM;
PATHOLOGICAL GAMBLING;
PERIPHERAL EDEMA;
PHARMACODYNAMICS;
QUALITY OF LIFE;
RESTLESS LEGS SYNDROME;
REVIEW;
RISK ASSESSMENT;
RISK REDUCTION;
SIDE EFFECT;
SINGLE DRUG DOSE;
SOMNOLENCE;
TREMOR;
UNSPECIFIED SIDE EFFECT;
VALVULAR HEART DISEASE;
VISUAL HALLUCINATION;
VOMITING;
WEIGHT REDUCTION;
XEROSTOMIA;
|
|
EID: 44049100761
PISSN: 11766328
EISSN: None
Source Type: Journal
DOI: 10.2147/ndt.s2325 Document Type: Review |
|
Times cited : (40)
|
|
References (136)
|
